pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 545 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
avexitide acetate
Hypoglycemia
$AMLXAmylyx Pharmaceuticals, Inc.
0 catalysts
Phase 3
avigbagene parvec
Gaucher Disease Type I
Spur Therapeutics Ltd
0 catalysts
Phase 3
axicabtagene ciloleucel
Yescarta (axicabtagene ciloleucel)
Diffuse Large B-Cell Lymphoma
B-lymphocyte antigen CD19
$GILDGILEAD SCIENCES, INC.
catalysts
← prev
page 7 of 19
next →
131
Pain89
Neurology1
0
Phase 3
azamidugene autotemcel
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Kyowa Kirin Co Ltd
0 catalysts
Phase 3
azeliragon
Coronavirus Disease 2019 (COVID-19)
Advanced glycosylation end product-specific receptor
Cantex Pharmaceuticals Inc
0 catalysts
Phase 3
azetukalner
Partial Seizure
$XENEXenon Pharmaceuticals Inc.
0 catalysts
Phase 3
baluretgene parvec
Retinitis Pigmentosa (Retinitis)
$OCGNOcugen, Inc.
0 catalysts
Phase 3
barzolvolimab
Chronic Urticaria
$CLDXCelldex Therapeutics, Inc.
0 catalysts
Phase 3
basimglurant
Trigeminal Neuralgia (Tic Douloureux)
Metabotropic glutamate receptor 5
Noema Pharma AG
0 catalysts
Phase 3
belapectin
Liver Cirrhosis
Galectin-3
$GALTGALECTIN THERAPEUTICS INC
0 catalysts
Phase 3
belimumab
Benlysta (belimumab)
Systemic Sclerosis (Scleroderma)
Tumor necrosis factor ligand superfamily member 13B
$GSKGSK plc
0 catalysts
Phase 3
belzupacap sarotalocan
Uveal Melanoma
$AURAAura Biosciences, Inc.
0 catalysts
Phase 3
bemdaneprocel
Parkinson's Disease
BlueRock Therapeutics LP
0 catalysts
Phase 3
bexicaserin
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Longboard Pharmaceuticals Inc
0 catalysts
Phase 3
bezisterim
Alzheimer's Disease
$BIVIBIOVIE INC.
0 catalysts
Phase 3
bifikafusp alfa + onfekafusp alfa
Nidlegy (bifikafusp alfa [INN] + onfekafusp alfa [INN])
Metastatic Melanoma
Philogen SpA
0 catalysts
Phase 3
bimatoprost grenod
Ocular Hypertension
Kowa Co Ltd
0 catalysts
Phase 3
blarcamesine hydrochloride
Fragile X Syndrome
$AVXLANAVEX LIFE SCIENCES CORP.
0 catalysts
Phase 3
bomedemstat tosylate
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
$MRKMerck & Co., Inc.
0 catalysts
Phase 3
botaretigene sparoparvovec
Retinitis Pigmentosa (Retinitis)
Johnson & Johnson Innovative Medicine
0 catalysts
Phase 3
brelovitug
brelovitug [INN]
Hepatitis D
$MIRMMirum Pharmaceuticals, Inc.
0 catalysts
Phase 3
brilaroxazine hydrochloride
Schizophrenia
$RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC.
0 catalysts
Phase 3
brolucizumab
Beovu (brolucizumab)
Proliferative Diabetic Retinopathy (PDR)
Vascular endothelial growth factor A, long form
$NVSNOVARTIS AG
0 catalysts
Phase 3
bucindolol hydrochloride
Gencaro (bucindolol hydrochloride)
Atrial Fibrillation
Adrenergic receptor alpha-1Beta-1 adrenergic receptor
Genvara Biopharma Inc
0 catalysts
Phase 3
buntanetap tartrate
Parkinson's Disease
$ANVSAnnovis Bio, Inc.
0 catalysts
Phase 3
cadisegliatin
Type 1 Diabetes (Juvenile Diabetes)
$VTVTvTv Therapeutics Inc.
0 catalysts
Phase 3
caficrestat
Cardiomyopathy
Aldo-keto reductase family 1 member B1
Biossil Inc
0 catalysts
Phase 3
camlipixant
Chronic Cough
P2X purinoceptor 3
$GSKGSK plc
0 catalysts
Phase 3
carenoprazan hydrochloride
Duodenal Ulcer
Jiangsu Carephar Pharmaceutical Co Ltd
0 catalysts
Phase 3
carisbamate
Lennox-Gastaut Syndrome
SK Life Science Inc
0 catalysts